Quantitative proteomic profiling of pancreatic cancer juice
- 30 June 2006
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 6 (13) , 3871-3879
- https://doi.org/10.1002/pmic.200500702
Abstract
Pancreatic juice is an exceptionally rich source of cancer‐specific proteins shed from cancerous ductal cells into the pancreatic juice. Quantitative proteomic analysis of the proteins specific to pancreatic cancer juice has not previously been reported. We used isotope‐code affinity tag (ICAT) technology and MS/MS to perform quantitative protein profiling of pancreatic juice from pancreatic cancer patients and normal controls. ICAT technology coupled with MS/MS allows the systematic study of the proteome and measures the protein abundance in pancreatic juice with the potential for development of biomarkers. A total of 105 proteins were identified and quantified in the pancreatic juice from a pancreatic cancer patient, of which 30 proteins showed abundance changes of at least twofold in pancreatic cancer juice compared to normal controls. Many of these proteins have been externally validated. This is the first comprehensive study of the pancreatic juice proteome by quantitative global protein profiling, and the study reveals numerous proteins that are shown for the first time to be associated with pancreatic cancer, providing candidates for diagnostic biomarkers. One of the identified proteins, insulin‐like growth factor binding protein‐2 was further validated by Western blotting to be elevated in pancreatic cancer juice and overexpressed in pancreatic cancer tissue.Keywords
This publication has 42 references indexed in Scilit:
- Pancreatic Cancer Proteome: The Proteins That Underlie Invasion, Metastasis, and Immunologic EscapeGastroenterology, 2005
- Application of laser capture microdissection combined with two‐dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinomaProteomics, 2003
- Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database SearchAnalytical Chemistry, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Elevated Serum Insulin-Like Growth Factor-Binding Protein 2 (IGFBP-2) and Decreased IGFBP-3 in Epithelial Ovarian Cancer: Correlation with Cancer Antigen 125 and Tumor-Associated Trypsin InhibitorJournal of Clinical Endocrinology & Metabolism, 1997
- Serum trypsinogen-2 and trypsin-2-α1-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomasInternational Journal of Cancer, 1996
- An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein databaseJournal of the American Society for Mass Spectrometry, 1994
- Tumor-Associated Trypsin Inhibitor (Tati) in Benign and Malignant Gastric DiseaseScandinavian Journal of Clinical and Laboratory Investigation, 1991
- Resolution of Human Exocrine Pancreatic Juice Proteins by Reversed-Phase High Performance Liquid Chromatography (HPLC)Pancreas, 1990